NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of
common stock of Mylan Inc., predecessor of Mylan N.V., and/or Mylan N.V.
ordinary shares (NASDAQ:MYL) from February 28, 2013 through October 7,
2016, both dates inclusive (the “Class Period”) of the important
December 12, 2016 lead plaintiff deadline in the class action filed by
the firm.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants made
false and/or misleading statements and/or failed to disclose that: (1)
Mylan N.V. and Mylan Inc. incorrectly classified EpiPen as a generic
under the Medicaid Drug Rebate Program, which was financially
consequential for federal and state governments as it reduced the amount
of quarterly rebates Mylan N.V. and Mylan Inc. owed for EpiPen; (2)
between 2011 through 2015, Mylan N.V. and Mylan Inc. paid a lower rebate
of 13% when it should have been paying a higher rebate of 23.1% or more;
(3) the incorrect classification appears to have cost the federal
government more than $100 million in the last five years alone; (4) in
turn, Mylan N.V. and Mylan Inc. lacked effective internal controls over
financial reporting; and (5) as a result, Mylan N.V. and Mylan Inc.’s
public statements were materially false and misleading at all relevant
times. The lawsuit claims that investors suffered damages when these
details entered the market.

A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than December 12, 2016.
If you wish to join the litigation, go to http://www.rosenlegal.com/cases-967.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at
866-767-3653 or via email at pkim@rosenlegal.com
or kchan@rosenlegal.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.